Keywords: domantis/peptech, anti-tnf, alpha, antibody, ra, uk, firm

Domantis/Peptech's anti-TNF alpha antibody in RA

Article | 02 June 2003

Print This

UK firm Domantis and Australia's Peptech claim to have achieved "outstanding" preclinical results for their lead human anti-TNF alpha domain ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in